Vaccine Product and Administration Reimbursement

THIRD-PARTY PAYORS / REIMBURSEMENT

Vaccine Product and Administration Reimbursement

RESOLVED, That the North Carolina Medical Society supports vaccine product reimbursement levels of at least the physician’s reasonable acquisition cost; and be it further

RESOLVED, That the North Carolina Medical Society supports vaccine administration reimbursement levels of at least the Medicare vaccine administration fee schedule for North Carolina; and be it further

RESOLVED, That the North Carolina Medical Society supports balance billing by physicians for the difference between the reasonable acquisition costs of the vaccine product and the reimbursement by the health insurance plan for the vaccine product.

(Resolution 21-2006, adopted as amended 10/29/2006)
(reaffirmed, Reaffirmation Report-2013, Item 70, adopted 10/26/2013)
(reaffirmed, Board Report-2018, Item 201, adopted 11/3/2018)

 
 

More Posts in

 
 

Share this Post